{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":37,"cheight":29,"picBdRadio":"0","borderType":"solid","jump":"0","definedUrl":"","isPicBd":"0","effectBdLine":"solid","image":"http://oss.xinghuo86.cn/666753113784399/698049634500727.png","picWidth":40,"picHeight":29,"inpColor":"","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true}
聯系電話：0851-33411018（行政部） 0851-88173360（銷售部） 股票代碼：SZ 002424
新聞詳情新京報 | 貴州百靈去年凈利潤預增超36% 發布日期：2023-02-01 15:59:17瀏覽量：466 新京報訊（記者張秀蘭）1月31日，貴州百靈發布2022年業績預告，報告期內預計實現凈利潤1.7億元-2億元，相較于上年同期的1.24億元，預增36.87%-61.02%。
貴州百靈集苗藥研發、生產、銷售于一體，擁有多個獨家苗藥產品，包括銀丹心腦通軟膠囊、咳速停糖漿等，在心腦血管類、咳嗽類、感冒類市場中占有一定市場份額。
貴州百靈表示，2022年12月以來，疫情防控整體調整和優化，防控相關藥品市場需求增加，咳速停糖漿、消咳顆粒、風寒感冒顆粒等咳嗽類、感冒類、退熱類等相關藥品銷量增長幅度較大，推動經營業績的提升。其中，咳速停糖漿在2022年12月獲得公司成立以來最大訂單，并與九州通醫藥集團簽訂《戰略保供協議》，優先保障九州通及其下屬子公司防疫產品咳速停糖漿的供應，雙方合作目標達5億元，預計將對2023年營業收入和利潤產生積極影響。
校對 盧茜 |
聯系我們
聯系電話：
0851-33411018（行政部）
0851-88173360（銷售部）
地址：貴州省安順市經濟技術
開發區西航大道
傳真：0851-33411559
關注我們
掃一掃 關注公眾號
{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":96,"cheight":98,"picBdRadio":"0","borderType":"solid","jump":"0","definedUrl":"","isPicBd":"0","effectBdLine":"solid","image":"http://oss.xinghuo86.cn/666753113784399/698049642889260.png","picWidth":100,"picHeight":98,"inpColor":"","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true}
{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":1220,"cheight":39,"picBdRadio":"0","borderType":"solid","jump":"0","definedUrl":"","isPicBd":"0","effectBdLine":"solid","image":"http://oss.xinghuo86.cn/666753113784399/698049642889261.webp","picWidth":1220,"picHeight":39,"inpColor":"","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true}